Cell Signaling Technology

RasGRP3 (C33A3) Rabbit Monoclonal Antibody

#3334 · western blot · $158,348

60

Evidence Score · Well-Established

Used by 98 independent labs across 100 papers. How we score this →

100

Citing papers

12k

Combined citations

Supplier page Find this product

Research areas

Cytokine Signaling Pathways and Interactions9 Hippo pathway signaling and YAP/TAZ8 Cancer, Hypoxia, and Metabolism7 Lung Cancer Treatments and Mutations6 HER2/EGFR in Cancer Research6 Neuroscience and Neuropharmacology Research5 Chronic Myeloid Leukemia Treatments4 Nerve injury and regeneration4

Papers citing this product

1

Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis

Genes & Development·2003·681 cit.·DOI

2

AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells

Nature Communications·2019·360 cit.·DOI

3

Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group

Blood·2009·345 cit.·DOI

4

GABA interneurons are the cellular trigger for ketamine’s rapid antidepressant actions

Journal of Clinical Investigation·2019·341 cit.·DOI

5

Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation

Genes & Development·2013·339 cit.·DOI

6

Catalytic activity tunable ceria nanoparticles prevent chemotherapy-induced acute kidney injury without interference with chemotherapeutics

Nature Communications·2021·297 cit.·DOI

7

Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer

Cancer Research·2004·295 cit.·DOI

8

Adaptable haemodynamic endothelial cells for organogenesis and tumorigenesis

Nature·2020·253 cit.·DOI

9

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion

Nature Communications·2024·237 cit.·DOI

10

Atypical Melanocytic Proliferations and New Primary Melanomas in Patients With Advanced Melanoma Undergoing Selective <i>BRAF</i> Inhibition

Journal of Clinical Oncology·2012·225 cit.·DOI

Rate this reagent

Used this in your lab? Leave a quick rating. Reviews are anonymous and verified by academic email before they appear.